Watch Out GSK! China’s Homegrown Shingles Vaccine Set To Soar
Other Competitors Looming
Although the domestic developer did not provide sales figures for 2023, a new homegrown shingles vaccine in China is poised to eat into the market share of GSK’s Shingrix in the country.
